Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down before the market opened on Monday . The stock had previously closed at $9.99, but opened at $9.03. Curaleaf shares last traded at $9.70, with a volume of 7,706 shares changing hands.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CURLF. Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Citigroup reiterated a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Three analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

Curaleaf Stock Up 0.9%

The company has a fifty day moving average of $7.87 and a two-hundred day moving average of $7.91. The company has a market cap of $2.29 billion, a PE ratio of -75.30 and a beta of 1.56. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.73 and a current ratio of 1.52.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. The firm had revenue of $340.10 million during the quarter, compared to analysts’ expectations of $332.00 million. As a group, analysts anticipate that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.